×
Back to Agenda
Meeting in the Middle: Best Practices for Collaboration Between Medical Affairs and Clinical Development
Session Chair(s)
J. Lynn Bass
Medical Affairs Lead
Mesoblast, Inc, United States
Medical affairs and clinical development enhance the scientific credibility of the company (and its products) with established and emerging clinical investigators These collaborations may also improve study recruitment techniques.
Learning Objective : Design new activities which require participation from both medical affairs and clinical development; Demonstrate how the medical affairs team can provide real-world data to help inform study designs and execution; Critique case studies of successful collaborations.
Speaker(s)
Industry Update
J. Lynn Bass
Mesoblast, Inc, United States
Medical Affairs Lead
Industry Update
Rebecca Vermeulen, RPH
Genentech, A Member of the Roche Group, United States
Vice President, Global Patient Networks | PD Medical Affairs
Industry Update
Sonja Hokett, PHARMD, MS, MSC
Mesoblast, United States
Have an account?